Stablishment of Prevention and Treatment System for Intestinal Dysfunction

Nanjing University School of Medicine50 enrolled

Overview

Dysfunction and intestinal endocrine dysfunction. This project will use genomics, metabonomics, microbiome and other omics techniques to study the clinical pathway of CID integrated therapy.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

Conditions

Bowel Dysfunction

Interventions

Nutritional Therapy, Metabolic Disorder, RegularDRUG

According to the result reported by Byrne, Wilmore, etc. in 1992 \~ 1995, the use of growth hormone, glutamine, modified diet and other measures proposed intestinal rehabilitation treatment. Then, check the patient's quality of life survey, nutritional status, inflammation indicators and other changes every three months, and use metabolomics and microbiomic tools to detect changes in the patient's nutritional metabolism, intestinal microecology, etc., and adjust the patient's nutritional treatment and microecological treatment based on the results Program.

Eligibility

Sex: ALLMin age: 18 YearsMax age: 65 Years

Medical Language ↔ Plain English

Inclusion Criteria: * The Patients with chronic bowel dysfunction Exclusion Criteria: * Past severe underlying diseases of the respiratory system and cardiovascular system, * Allergy to treatment-related drugs, * Pregnancy, * Accept CID surgery.

Outcomes

Primary Outcomes

nutrition index

Time frame: 3 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.